Voyageur Pharmaceuticals Ltd. (VM.V)

CAD 0.11

(50.0%)

Gross Profit Summary of Voyageur Pharmaceuticals Ltd.

  • Voyageur Pharmaceuticals Ltd.'s latest annual gross profit in 2023 was -2185.00 CAD , up 24.86% from previous year.
  • Voyageur Pharmaceuticals Ltd.'s latest quarterly gross profit in 2024 Q3 was -393.00 CAD , down 0.0% from previous quarter.
  • Voyageur Pharmaceuticals Ltd. reported a annual gross profit of -2908.00 CAD in annual gross profit 2022, down -29.47% from previous year.
  • Voyageur Pharmaceuticals Ltd. reported a annual gross profit of -2246.00 CAD in annual gross profit 2021, down -51.45% from previous year.
  • Voyageur Pharmaceuticals Ltd. reported a quarterly gross profit of -393.00 CAD for 2024 Q1, up 28.02% from previous quarter.
  • Voyageur Pharmaceuticals Ltd. reported a quarterly gross profit of -393.00 CAD for 2024 Q3, down 0.0% from previous quarter.

Annual Gross Profit Chart of Voyageur Pharmaceuticals Ltd. (2023 - 2011)

Historical Annual Gross Profit of Voyageur Pharmaceuticals Ltd. (2023 - 2011)

Year Gross Profit Gross Profit Growth
2023 -2185.00 CAD 24.86%
2022 -2908.00 CAD -29.47%
2021 -2246.00 CAD -51.45%
2020 -1483.00 CAD 30.05%
2019 -2120.00 CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 100.0%
2016 -113.53 Thousand CAD 17.26%
2015 -137.22 Thousand CAD 0.0%
2014 - CAD 0.0%
2013 - CAD 0.0%
2012 - CAD 0.0%
2011 - CAD 0.0%

Peer Gross Profit Comparison of Voyageur Pharmaceuticals Ltd.

Name Gross Profit Gross Profit Difference
Aequus Pharmaceuticals Inc. 5499.00 CAD 139.734%
CanadaBis Capital Inc. 11.78 Million CAD 100.019%
Decibel Cannabis Company Inc. 41.85 Million CAD 100.005%
Delivra Health Brands Inc. 6.39 Million CAD 100.034%
Entourage Health Corp. 3.7 Million CAD 100.059%
Lifeist Wellness Inc. 5.34 Million CAD 100.041%
Cannara Biotech Inc. 27.23 Million CAD 100.008%
Medicure Inc. 13.98 Million CAD 100.016%
PharmaCielo Ltd. -1.36 Million CAD 99.84%
Rubicon Organics Inc. 13.14 Million CAD 100.017%
BioSyent Inc. 25.14 Million CAD 100.009%